RecruitingPhase 4NCT06332040

Gentamicin Bladder Instillation on CAUTI

A Randomized Controlled Trial to Evaluate the Effectiveness of Gentamicin Bladder Instillation on CAUTI


Sponsor

St. Joseph's Hospital and Medical Center, Phoenix

Enrollment

400 participants

Start Date

Oct 9, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Urinary tract infections in catheterized patients is an unacceptable complication and has been termed a 'never event' by the Center for Medicare \& Medicaid Services (CMS); however there is not consensus among clinicians on how to best prevent CAUTIs. We propose a prospective randomized controlled trial to test the efficacy of prophylactic gentamicin bladder irrigation in elimination of CAUTIs.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • age greater than 18
  • admitted with a trauma, surgical, or neuro-critical care diagnosis
  • indwelling foley catheter in place

Exclusion Criteria5

  • Documented positive UA or Urine Culture within the past 7 days or upon admission
  • Traumatic bladder injury
  • Gross hematuria
  • Chronic indwelling urethral or chronic suprapubic foley catheter
  • allergy to gentamicin or similar aminoglycosides

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGentamicin

random assignment to gentamicin or placebo bladder instillation to prevent CAUTI (catheterized urinary track infection)


Locations(1)

St. Jpseph's Hospital and Medical Center

Phoenix, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06332040


Related Trials